All lobbying filings
LMH STRATEGIC SOLUTIONS
LMH STRATEGIC SOLUTIONS filed a Q3 report for REGENXBIO INC. on October 20, 2025, reporting $60,000 in lobbying income.
Lobbying for REGENXBIO INC. · Biotechnology company.
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Income
$60,000
What the client paid this registrant for the period.
Client based in
Maryland
Lobbyists on this filing
1
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
Government bodies contacted
4
Lobbying activity
2
Prescription drug payment reform. Pharmaceutical supply chain.
General Medicare and Medicaid Issues.